Pharmaceutical

FDA committee proposes overhaul of perioperative lung cancer trials 

The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.

Jul 28, 2024 - 04:00
FDA committee proposes overhaul of perioperative lung cancer trials 
The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.
Read the original article

Tags:

Previous Article

Balancing instability and robustness: new mathematical framework to understand d...

Next Article

EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Walden Biosciences teams up with Primula for kidney disease study 

Walden Biosciences teams up with Primula for kidney dis...

May 15, 2024

STAT+: From ‘Jeopardy!’ to Politico, the PBM ad wars are taking over D.C.

STAT+: From ‘Jeopardy!’ to Politico, the PBM ad wars ar...

Jul 6, 2023

Preterm birth and infant mortality measures in U.S. remain stubbornly high

Preterm birth and infant mortality measures in U.S. rem...

Nov 17, 2023